Sun Pharmaceutical ties up with Israel varsity for cancer research

16 Apr 2015 Evaluate

Sun Pharmaceutical Industries has entered into an exclusive worldwide research and licence agreement for the development of novel anti-cancer drugs with the Technion-Israel institute of technology.

The joint project would be based on new findings by Nobel Prize laureate Professor Aaron Ciechanover, Gila Maor and Professor Ofer Binah. The research development comes weeks after Sun sealed its $4-billion deal to merge troubled drugmaker Ranbaxy.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Peers
Company Name CMP
Sun Pharma Inds. 1522.05
Dr. Reddys Lab 6262.40
Cipla 1399.75
Zydus Lifesciences 960.50
Lupin 1634.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.